nivolumab,pembrolizumab,ipilimumab
merck,bms
['melanoma', 'nadina', 'swog 1801']
international neoadjuvant melanoma consortium #inmc meeting. amazing location discussing the future of #neoadjuvant therapy in #melanoma. neoadj will be standard with 2 randomised trials nadina &amp; swog 1801. swog to be presented this #esmo22. what s next? mx guideline updates asap 
Co-Medical Director and Medical Oncologist Melanoma Institute Australia.